{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:03Z","timestamp":1792190583403,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Women with a personal history of breast cancer have an increased risk of subsequent breast malignancy and may benefit from more sensitive surveillance than conventional mammography (MG). We previously reported outcomes for first surveillance episode using contrast-enhanced mammography (CEM), demonstrating higher sensitivity and comparable specificity to MG. We now report CEM performance for subsequent surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study of 1,190 women in an Australian hospital setting undergoing annual surveillance following initial surveillance CEM between June 2016 and December 2022. Outcome measures were recall rate, cancer detection rate, contribution of contrast to recalls, false positive rate, interval cancer rate and characteristics of surveillance detected and interval cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>2,592 incident surveillance episodes were analysed, of which 93% involved contrast-based imaging. Of 116 (4.5%) recall episodes, 40\/116 (34%) recalls were malignant (27 invasive; 13 ductal carcinoma in situ), totalling 15.4 cancers per 1000 surveillance episodes. 55\/116 (47%) recalls were contrast-directed including 17\/40 (43%) true positive recalls. Tumour features were similar for contrast-directed recalls and other diagnoses. 8\/9 (89%) of contrast-directed invasive recalls were Grade 2\u20133, and 5\/9 (56%) were triple negative breast cancers. There were two symptomatic interval cancers (0.8 per 1000 surveillance episodes, program sensitivity 96%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Routine use of CEM in surveillance of women with PHBC led to an increase in the detection of clinically significant malignant lesions, with a low interval cancer rate compared to previous published series. Compared to mammographic surveillance, contrast-enhanced mammography increases the sensitivity of surveillance programs for women with PHBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-024-07419-2","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T04:14:55Z","timestamp":1720066495000},"page":"293-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer"],"prefix":"10.1007","volume":"208","author":[{"given":"Julia","family":"Matheson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Nickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Bruce","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"7419_CR1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/jama.2011.188","volume":"305","author":"N Houssami","year":"2011","unstructured":"Houssami N, Abraham LA, Miglioretti DL et al (2011) Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 305:790\u2013799. https:\/\/doi.org\/10.1001\/jama.2011.188","journal-title":"JAMA"},{"key":"7419_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5694\/j.1326-5377.2011.tb03054.x","volume":"194","author":"N Houssami","year":"2011","unstructured":"Houssami N, Miglioretti DL (2011) Early detection of breast cancer the second time around: mammography in women with a personal history of breast cancer. Med J Aust 194:439\u2013440. https:\/\/doi.org\/10.5694\/j.1326-5377.2011.tb03054.x","journal-title":"Med J Aust"},{"key":"7419_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10549-010-1106-6","volume":"124","author":"DSM Buist","year":"2010","unstructured":"Buist DSM, Abraham LA, Barlow WE et al (2010) Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Tr 124:863\u2013873. https:\/\/doi.org\/10.1007\/s10549-010-1106-6","journal-title":"Breast Cancer Res Tr"},{"key":"7419_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2214\/ajr.16.16300","volume":"208","author":"DL Lam","year":"2017","unstructured":"Lam DL, Houssami N, Lee JM (2017) Imaging surveillance after primary breast cancer treatment. Am J Roentgenol 208:676\u2013686. https:\/\/doi.org\/10.2214\/ajr.16.16300","journal-title":"Am J Roentgenol"},{"key":"7419_CR5","unstructured":"Network NCC NCCN clinical practice guidelines in oncology: breast cancer. Version 4.2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"},{"key":"7419_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2214\/ajr.22.27635","volume":"219","author":"MB Lawson","year":"2022","unstructured":"Lawson MB, Herschorn SD, Sprague BL et al (2022) Imaging surveillance options for individuals with a personal history of breast cancer: AJR expert panel narrative review. Am J Roentgenol 219:854\u2013868. https:\/\/doi.org\/10.2214\/ajr.22.27635","journal-title":"Am J Roentgenol"},{"key":"7419_CR7","doi-asserted-by":"publisher","first-page":"e2121505","DOI":"10.1001\/jamanetworkopen.2021.21505","volume":"4","author":"N Harada-Shoji","year":"2021","unstructured":"Harada-Shoji N, Suzuki A, Ishida T et al (2021) Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40\u201349 years with varying breast density undergoing screening mammography. Jama Netw Open 4:e2121505. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21505","journal-title":"Jama Netw Open"},{"key":"7419_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0140-6736(15)00774-6","volume":"387","author":"N Ohuchi","year":"2016","unstructured":"Ohuchi N, Suzuki A, Sobue T et al (2016) Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan strategic anti-cancer randomized trial (J-START): a randomised controlled trial. Lancet 387:341\u2013348. https:\/\/doi.org\/10.1016\/s0140-6736(15)00774-6","journal-title":"Lancet"},{"key":"7419_CR9","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1001\/jama.299.18.2151","volume":"299","author":"WA Berg","year":"2008","unstructured":"Berg WA, Blume JD, Cormack JB et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299:2151\u20132163. https:\/\/doi.org\/10.1001\/jama.299.18.2151","journal-title":"JAMA"},{"key":"7419_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1148\/radiol.2021203074","volume":"300","author":"GR Kim","year":"2021","unstructured":"Kim GR, Cho N, Kim S-Y et al (2021) Interval cancers after negative supplemental screening breast mri results in women with a personal history of breast cancer. Radiology 300:314\u2013323. https:\/\/doi.org\/10.1148\/radiol.2021203074","journal-title":"Radiology"},{"key":"7419_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12885-022-09792-x","volume":"22","author":"MM Fonseca","year":"2022","unstructured":"Fonseca MM, Alhassan T, Nisha Y et al (2022) Randomized trial of surveillance with abbreviated MRI in women with a personal history of breast cancer\u2013impact on patient anxiety and cancer detection. BMC Cancer 22:774. https:\/\/doi.org\/10.1186\/s12885-022-09792-x","journal-title":"BMC Cancer"},{"key":"7419_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10549-020-05637-y","volume":"181","author":"CB Haas","year":"2020","unstructured":"Haas CB, Nekhlyudov L, Lee JM et al (2020) Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis. Breast Cancer Res Tr 181:255\u2013268. https:\/\/doi.org\/10.1007\/s10549-020-05637-y","journal-title":"Breast Cancer Res Tr"},{"key":"7419_CR13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S et al (2019) Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up \u2020. Ann Oncol 30:1194\u20131220. https:\/\/doi.org\/10.1093\/annonc\/mdz173","journal-title":"Ann Oncol"},{"issue":"6","key":"7419_CR14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3322\/caac.21319","volume":"34","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL et al (2016) (2016) American cancer society\/American society of clinical oncology breast cancer survivorship care guideline. J Clin Oncol 34(6):611\u2013635. https:\/\/doi.org\/10.3322\/caac.21319","journal-title":"J Clin Oncol"},{"issue":"174","key":"7419_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7150\/jca.79747","volume":"14","author":"LM Neeter","year":"2023","unstructured":"Neeter LM, Robbe MQ, van Nijnatten TJ, Jochelson MS, Raat HP, Wildberger JE, Smidt ML, Nelemans PJ, Lobbes MB (2023) Comparing the diagnostic performance of contrast-enhanced mammography and breast MRI: a systematic review and meta-analysis. J Cancer 14(174):182. https:\/\/doi.org\/10.7150\/jca.79747","journal-title":"J Cancer"},{"key":"7419_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10549-023-06916-0","volume":"199","author":"K Elder","year":"2023","unstructured":"Elder K, Matheson J, Nickson C et al (2023) Contrast enhanced mammography in breast cancer surveillance. Breast Cancer Res Treat 199:221\u2013230. https:\/\/doi.org\/10.1007\/s10549-023-06916-0","journal-title":"Breast Cancer Res Treat"},{"key":"7419_CR17","doi-asserted-by":"crossref","unstructured":"Morris E, Comstock C, Lee C, al et (2013) ACR BI-RADS\u00ae Magnetic resonance imaging. In: ACR BI-RADS\u00ae atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA","DOI":"10.1016\/j.mric.2013.04.006"},{"key":"7419_CR18","unstructured":"Lee C, Phillips J, Sung J, et al (2022) Contrast-enhanced mammography (CEM). a supplement to ACR BIRADS\u00ae mammography 2013. American College of Radiology, Reston, VA"},{"key":"7419_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41523-022-00448-4","volume":"8","author":"R Yoder","year":"2022","unstructured":"Yoder R, Kimler BF, Staley JM et al (2022) Impact of low versus negative estrogen\/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer. Npj Breast Cancer 8:80. https:\/\/doi.org\/10.1038\/s41523-022-00448-4","journal-title":"Npj Breast Cancer"},{"key":"7419_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/jco.19.02309","volume":"38","author":"KH Allison","year":"2020","unstructured":"Allison KH, Hammond MEH, Dowsett M et al (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update. J Clin Oncol 38:1346\u20131366. https:\/\/doi.org\/10.1200\/jco.19.02309","journal-title":"J Clin Oncol"},{"key":"7419_CR21","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1200\/jco.2009.25.6529","volume":"28","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M et al (2010) American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784\u20132795. https:\/\/doi.org\/10.1200\/jco.2009.25.6529","journal-title":"J Clin Oncol"},{"key":"7419_CR22","unstructured":"Stata statistical software: release 15 (2017) StataCorp LLC, College Station, TX, USA"},{"key":"7419_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1148\/radiol.2021204581","volume":"300","author":"JM Lee","year":"2021","unstructured":"Lee JM, Ichikawa LE, Wernli KJ et al (2021) Digital mammography and breast tomosynthesis performance in women with a personal history of breast cancer, 2007\u20132016. Radiology 300:290\u2013300. https:\/\/doi.org\/10.1148\/radiol.2021204581","journal-title":"Radiology"},{"key":"7419_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.18179","volume":"3","author":"S Niraula","year":"2020","unstructured":"Niraula S, Biswanger N, Hu P et al (2020) Incidence, characteristics, and outcomes of interval breast cancers compared with screening-detected breast cancers. JAMA Netw Open 3:e2018179. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.18179","journal-title":"JAMA Netw Open"},{"key":"7419_CR25","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.3390\/cancers12123495","volume":"12","author":"J Gluskin","year":"2020","unstructured":"Gluskin J, Saccarelli CR, Avendano D et al (2020) Contrast-enhanced mammography for screening women after breast conserving surgery. Cancers 12:3495. https:\/\/doi.org\/10.3390\/cancers12123495","journal-title":"Cancers"},{"key":"7419_CR26","doi-asserted-by":"publisher","first-page":"182660","DOI":"10.1148\/radiol.2019182660","volume":"293","author":"JS Sung","year":"2019","unstructured":"Sung JS, Lebron L, Keating D et al (2019) Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer. Radiology 293:182660. https:\/\/doi.org\/10.1148\/radiol.2019182660","journal-title":"Radiology"},{"key":"7419_CR27","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jama.2012.388","volume":"307","author":"WA Berg","year":"2012","unstructured":"Berg WA, Zhang Z, Lehrer D et al (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307:1394\u20131404. https:\/\/doi.org\/10.1001\/jama.2012.388","journal-title":"JAMA"},{"key":"7419_CR28","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203633","volume":"299","author":"SGA Veenhuizen","year":"2021","unstructured":"Veenhuizen SGA, de Lange SV, Bakker MF et al (2021) Supplemental breast MRI for women with extremely dense breasts: results of the second screening round of the DENSE trial. Radiology 299:203633. https:\/\/doi.org\/10.1148\/radiol.2021203633","journal-title":"Radiology"},{"key":"7419_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","volume":"114","author":"WL Lu","year":"2008","unstructured":"Lu WL, Jansen L, Post WJ et al (2008) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Tr 114:403. https:\/\/doi.org\/10.1007\/s10549-008-0023-4","journal-title":"Breast Cancer Res Tr"},{"key":"7419_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1148\/radiol.2019182475","volume":"292","author":"KJ Wernli","year":"2019","unstructured":"Wernli KJ, Ichikawa L, Kerlikowske K et al (2019) Surveillance breast mri and mammography: comparison in women with a personal history of breast cancer. Radiology 292:311\u2013318. https:\/\/doi.org\/10.1148\/radiol.2019182475","journal-title":"Radiology"},{"key":"7419_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1148\/radiol.2021211080","volume":"300","author":"PJ Slanetz","year":"2021","unstructured":"Slanetz PJ (2021) MRI screening of women with a personal history of breast cancer. Radiology 300:324\u2013325. https:\/\/doi.org\/10.1148\/radiol.2021211080","journal-title":"Radiology"},{"key":"7419_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1148\/radiol.2019182441","volume":"292","author":"CM Thompson","year":"2019","unstructured":"Thompson CM, Mallawaarachchi I, Dwivedi DK et al (2019) The Association of background parenchymal enhancement at breast MRI with breast cancer: a systematic review and meta-analysis. Radiology 292:552\u2013561. https:\/\/doi.org\/10.1148\/radiol.2019182441","journal-title":"Radiology"},{"key":"7419_CR33","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1200\/jco.18.00378","volume":"37","author":"VA Arasu","year":"2019","unstructured":"Arasu VA, Miglioretti DL, Sprague BL et al (2019) Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk. J Clin Oncol 37:954\u2013963. https:\/\/doi.org\/10.1200\/jco.18.00378","journal-title":"J Clin Oncol"},{"key":"7419_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1001\/jamasurg.2023.2150","volume":"158","author":"J-H Cheun","year":"2023","unstructured":"Cheun J-H, Kim H-K, Moon H-G et al (2023) locoregional recurrence patterns in patients with different molecular subtypes of breast cancer. JAMA Surg 158:841\u2013852. https:\/\/doi.org\/10.1001\/jamasurg.2023.2150","journal-title":"JAMA Surg"},{"key":"7419_CR35","doi-asserted-by":"crossref","unstructured":"J D, Donnelly P, Elbeltagi N, et al (2023) Mammographic surveillance in early breast cancer patients aged 50 years or over: results of the mammo-50 non-inferiority trial of annual versus less frequent mammography. In: San Antonio Breast cancer Symposium","DOI":"10.1158\/1538-7445.SABCS23-GS03-02"},{"key":"7419_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jacr.2023.05.014","volume":"20","author":"WA Berg","year":"2023","unstructured":"Berg WA, Bandos AI, Sava MG (2023) Analytic hierarchy process analysis of patient preferences for contrast-enhanced mammography versus mri as supplemental screening options for breast cancer. J Am Coll Radiol 20:758\u2013768. https:\/\/doi.org\/10.1016\/j.jacr.2023.05.014","journal-title":"J Am Coll Radiol"},{"key":"7419_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejrad.2017.07.004","volume":"94","author":"IPL Houben","year":"2017","unstructured":"Houben IPL, de Voorde PV, Jeukens CRLPN et al (2017) Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits. Eur J Radiol 94:31\u201337. https:\/\/doi.org\/10.1016\/j.ejrad.2017.07.004","journal-title":"Eur J Radiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07419-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T05:08:11Z","timestamp":1728104891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07419-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7419"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07419-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"28 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author GBM has received research support from Hologic. Author AKR has served once on an advisory board for Hologic. All other authors declare no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Author GBM has received research support from Hologic. Author AKR has served once on an advisory board for Hologic. All other authors declare no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The project was approved by the Melbourne Health Research and Ethics Committee as a Quality Assurance project (QA2019129).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}